[HTML][HTML] Using artificial intelligence-based methods to address the placebo response in clinical trials
EA Smith, WP Horan, D Demolle… - Innovations in Clinical …, 2022 - ncbi.nlm.nih.gov
The placebo response is a highly complex psychosocial-biological phenomenon that has
challenged drug development for decades, particularly in neurological and psychiatric …
challenged drug development for decades, particularly in neurological and psychiatric …
Leveraging historical data to optimize the number of covariates and their explained variance in the analysis of randomized clinical trials.
S Branders, A Pereira, G Bernard… - … Methods in Medical …, 2022 - journals.sagepub.com
The amount of data collected from patients involved in clinical trials is continuously growing.
All baseline patient characteristics are potential covariates that could be used to improve …
All baseline patient characteristics are potential covariates that could be used to improve …
[HTML][HTML] Report of similar placebo response in one internet versus onsite randomised controlled trials from the literature
Objective The aim of this study was to compare the magnitude and the predictors of the
placebo response in an internet versus onsite randomised controlled trials (RCTs) in people …
placebo response in an internet versus onsite randomised controlled trials (RCTs) in people …
[PDF][PDF] Predicting the Placebo Response
E Smith, A Pereira, S Branders, D Demolle - 2021 - cognivia.com
The influence of patient psychology on response to treatment and placebo can no longer be
ignored. Tools4Patient (T4P) provides proven solutions that use insights from clinical trial …
ignored. Tools4Patient (T4P) provides proven solutions that use insights from clinical trial …
[HTML][HTML] Using Machine Learning to Predict Placebo Response and Increase Clinical Trial Success
E Smith - appliedclinicaltrialsonline.com
Every year, the pharmaceutical industry spends millions in an effort to improve the
evaluation of efficacy in clinical trials–including strategies to reduce risk relating to the …
evaluation of efficacy in clinical trials–including strategies to reduce risk relating to the …